Form D · Biotechnology
Lupvindol Biosciences LTD
Sheridan, WY · CIK 0002047889
Offering snapshot reported Dec 23, 2024 · SEC filing
- Reported sold
- $2.2M Offering amount: $12M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Oct 25, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 23, 2024 | Initial | $2,200,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-533076
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| None | None |
Source: Form D, filed Dec 23, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Hunter Land | Director, Executive |
| Timothy Rogers | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
30 N Gould St Ste R
Sheridan, WY, 82801
Sheridan, WY, 82801